Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab.

J Pers Med · 2025 · PMC11856950 · PMID 39997320

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The ACT score also improved by two points from 15 ± 5 to 17 ± 5 ( p = 0.056) and did not reach statistical significance or minimal clinically important differences (MCID).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.